Abdul Latif Jameel Health, Wellesta Holdings collaborate to market Butterfly iQ+ point-of-care ultrasound device in India

The innovative Butterfly iQ+ is the world's first single probe, whole-body handheld point-of-care ultrasound solution. As part of its new agreement with Abdul Latif Jameel Health, Wellesta will register Butterfly iQ+ in India and start promoting and selling the product in the country in the fourth quarter of 2022, bringing this technology to a potential 1.2 million registered physicians in the country.

Today, more than 4.7 billion around the world lack access to medical imaging, from underserved communities in the United States to remote areas of Africa. 

This new collaboration will offer greater distribution of Butterfly iQ+ to physicians in India, thereby expanding the capabilities of the practitioners in making informed decisions thereby accelerating access to modern medical care for those who need it most.

Butterfly iQ+ is revolutionizing medical imaging. It is a hand-held 4-in-1 single probe whole-body innovative point-of-care ultrasound device powered by the world's only Ultrasound–on-Chip technology.

This point-of-care device with over 20 default pre-sets is compatible with both iOS and Android smart devices and comes complete with battery back, wireless charging, cloud storage, customized app., software, and AI support.

Hailed as potentially the 'stethoscope of the future, the Butterfly iQ+ transforms what can sometimes be complex processes into one connected and integrated point-of-care ultrasound (POCUS) system to help collect advanced imaging, perform rapid assessments, and guide critical procedures. It allows the sharing of results seamlessly with doctors across the globe to help read and interpret scans.

Speaking about this new collaboration, Milan Paleja, Chairman and Managing Director, Wellesta, said: "I am very excited to partner with Abdul Latif Jameel Health to market Butterfly iQ+ in India to bring this breakthrough Ultrasound-on-Chip technology in the Butterfly probe to this market. Its versatile, innovative ultrasound solution will assist healthcare professionals to obtain point-of-care ultrasound-driven insights - – across the vast country with a geographically disperse population to improve access to primary healthcare."

Akram Bouchenaki, Chief Executive Officer, Abdul Latif Jameel Health added: "Abdul Latif Jameel is addressing tangible real-world needs today for a better tomorrow. We are focused on healthcare inclusion, accelerating access to modern medical care for those who need it most.

"We believe in realizing the true power of deep local knowledge, relationships, and partnerships to get the very best results for the communities we serve. In India, I am proud to collaborate with Wellesta, who share our vision of improving live and lives across the Global South."